CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.
Cannabis stocks and ETFs jumped last week. Here's why.
"Essential Business" status tagged with marijuana selling amid lockdowns should have helped cannabis stocks and ETFs in the first quarter.
Marijuana companies are witnessing robust demand amid the coronavirus outbreak. Time to buy some earlier-battered marijuana stocks and ETFs?
Solid earnings drive Canopy Growth stock and boost the industry as a result. Is it right time to buy marijuana ETFs?
The year 2020 has so far been marked with Middle East tensions, the coronavirus outbreak and Wall Street rally. These sector ETFs have come across as winners and losers.
Inside the ETF areas that were winners last week.
With a greater legislative push to legalize recreational marijuana, cannabis ETFs are soaring to start the year and are likely to continue doing so.
Marijuana ETFs hit a high in 2018 only to experience a bloodbath in 2019. Let's see what lies in store for the space in 2020.
Inside the ETF gainers and losers of last week.
Inside the key ETF events of the month of November.
Cannabis spending rises over the Thanksgiving holiday period, especially Green Wednesday as well as on Black Friday.
Passing of a legalization bill by a U.S. congressional committee boosted the battered marijuana ETF space lately.
A wave of disappointing earnings caused a bloodbath in marijuana ETFs last week. However, talks of an end to the federal embargo on marijuana could turn this segment around.
Hexo's downbeat results weigh on marijuana space but many key pot companies are likely to beat in November. This could provide a good entry points to pot ETFs.
Signs of some progress in the U.S.-China trade relation, Brexit doldrums, oil price rally and mixed earnings pulled the stings of the market movement and made these ETFs winners and losers.
As Global X launches a fresh pot ETF, let's explore the product in detail.
August was trade-war trodden and dealt a blow to the broader equity market. These sector ETFs were among the most-hurt ones.
HubSpot, Kraft Heinz, CNBS, Canopy Growth, Aurora Cannabis and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day
CNBC???s cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.